Warf 3 Tablet contains Warfarin 3 mg, an oral anticoagulant used to prevent and treat thromboembolic disorders. Warfarin acts by inhibiting the synthesis of vitamin K-dependent clotting factors II, VII, IX, and X, as well as anticoagulant proteins C and S, thereby reducing blood coagulation and preventing the formation of harmful clots. It is commonly prescribed for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation with embolization risk, and for the prevention of stroke in patients with prosthetic heart valves. The dosage of Warf 3 Tablet must be individualized based on the patient’s International Normalized Ratio (INR) to maintain therapeutic anticoagulation while minimizing the risk of bleeding complications. Regular monitoring of INR is essential during therapy to adjust the dose accordingly. Patients should be advised regarding potential drug and dietary interactions, as vitamin K intake and certain medications can significantly affect Warfarin’s efficacy. Caution is warranted in patients with bleeding disorders, hepatic impairment, or those undergoing surgery. Warf 3 Tablet should be used under strict medical supervision with careful monitoring to ensure safe and effective anticoagulation therapy.